Preventing and Curing HCV Among MSM Without HIV Infection
- What’s the Risk? Sexual HCV Transmission Among MSM
- Implications of HIV PrEP and HIV U = U for MSM Without HIV Infection
- Treating HCV Infection in MSM Without HIV
- Preventing Reinfection: Education and Counseling
Question and Answer Session
Date / Time
Mark Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and
Johns Hopkins University School of Medicine
Daniel S. Fierer, MD
Department of Infectious Diseases
Icahn School of Medicine at Mount Sinai
Head, Co-infection Clinic
Jack Martin Fund
Mount Sinai Medical Center
New York, New York
The primary purpose of this program is to increase awareness of HCV elimination goals and provide clinicians with practical strategies for meeting these goals within their practice settings. The program focuses on 3 principal at-risk populations that are critical to national HCV elimination goals: people who inject drugs, people who are incarcerated, and men who have sex with men.
The goal of this activity is to improve participants’ competence in implementing strategies to screen, diagnose, and cure diverse populations of individuals infected with HCV in the United States.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers involved in the screening, diagnosis, and treatment of patients infected with or at elevated risk of HCV.
- Apply strategies to improve rates of HCV screening, diagnosis, and engagement in care for MSM without HIV
- Educate MSM in your care on risk factors for HCV infection and harm reduction strategies that may reduce their risk
- Integrate HCV treatment as prevention strategies for appropriate patients with acute or newly diagnosed chronic HCV infection
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, American Society of Addiction Medicine, HealthHCV, and International Network for Hepatitis in Substance Users. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.7 contact hour.
Pharmacist Continuing Education
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-19-853-L01-P)
Type of Activity: Knowledge
Upon completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.